(2S,4S)-2-(Dimethylaminocarbonyl)-4-mercapto-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine

CAS : 96034-64-9

Ref. 3D-FD151235

Informations sur le produit

• Nom: (2S,4S)-2-(Dimethylaminocarbonyl)-4-mercapto-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine
• Synonymes: (2S,4S)-2-(Dimethylaminocarbonyl)-4-mercapto-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine(2S-cis)-2-[(Dimethylamino)carbonyl]-4-merca pto-1-pyrrolidinecarboxylicacid (4-nitrophenyl) methylester, ( 2S-CIS)side chain, (2S,4R)-2-carboxylic-4-hydroxy-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine, (2S,4S)-1-Pyrrolidinecarboxylic acid, 2-[(dimethylamino)carbonyl]-4-mercapto-, (4-nitrophenyl)methyl ester, (2S,4S)-2-( dimethylamino-carbonyl)-4-mercapto-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine, (2S,4S)-2-(Dimethylaminocarbonyl)-4-Mercapto-1-(P-Nitrobenzyloxycarbonyl)-1-Pyrrolidine, (2S,4S)-2-(dimethylamino-carbonyl)-4-mercapto-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine, (2S,4S)-2-Dimethylaminocarbonyl-4-mercapto-1-(p-nitrobenzyloxycarbonyl)-pyrrolidine, (2S,4S)-N,N-Dimethyl-1-(4-nitrobenzyloxycarbonyl)-4-mercaptopyrrolidine-2-carboxamide, (2S-Cis)-2-[(Dimethylamino)Carbonyl]-4-Mercapto-1-Pyrrolidinecarboxylic Acid (4-Nitrophenyl) Methyl Ester, (2S-cis)-2-[(dimethylamino)carbonyl]-4-mercapto-1-pyrrolidinecarboxylic acid, (4-Nitrophenyl)methyl (2S,4S)-2-[(dimethylamino)carbonyl]-4-mercapto-1-pyrrolidinecarboxylate, 1-Pyrrolidinecarboxylic acid, 2-[(dimethylamino)carbonyl]-4-mercapto-, (4-nitrophenyl)methyl ester, (2S,4S)-, 1-Pyrrolidinecarboxylic acid, 2-[(dimethylamino)carbonyl]-4-mercapto-, (4-nitrophenyl)methyl ester, (2S-cis)-, 2S-Cis, 4-nitrobenzyl (2S,4S)-2-(dimethylcarbamoyl)-4-sulfanylpyrrolidine-1-carboxylate, For Meropenem, Intermaterial of the side for penem, Meropenem Side Chain, Side Chain For Meropenem

Description

(2S,4S)-2-(Dimethylaminocarbonyl)-4-mercapto-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine is an insulin receptor antagonist that binds to the insulin receptor in the cell membrane and inhibits the activation of downstream signaling pathways, which leads to decreased insulin resistance. The compound has been shown to inhibit epidermal growth factor (EGF) induced proliferation of human keratinocytes in vitro and in vivo. This drug also blocks nicotinic acetylcholine receptors, leading to increased contractility of heart muscle cells in a rat model of congestive heart failure. It has been shown to have anti-inflammatory effects against infectious diseases such as influenza A virus, herpes simplex virus 1, or Candida albicans. It is a matrix metalloproteinase inhibitor that has been shown to have anti-tumor activity against human breast cancer cells. The drug is reactive

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 353.39 g/mol
• Formule: C₁₅H₁₉N₃O₅S
• Degré de pureté: Min. 95%